TY - JOUR
T1 - Phenotypic Variation and Pubertal Outcomes in Males and Females with 46,XY Partial Gonadal Dysgenesis
AU - Tadokoro-Cuccaro, Rieko
AU - Hughes, Ieuan A
AU - Cools, Martine
AU - van de Vijver, Koen
AU - Bilharinho de Mendonça, Berenice
AU - Domenice, Sorahia
AU - Loch Batista, Rafael
AU - Thomazini Dallago, Renata
AU - F Costa, Elaine
AU - Lisboa Gomes, Nathalia
AU - T Maciel-Guerra, Andréa
AU - Guerra-Junior, Gil
AU - Gabriel Ribeiro de Andrade, Juliana
AU - Lucas-Herald, Angela
AU - Bryce, Jillian
AU - Hannema, Sabine
AU - Juul, Anders
AU - Globa, Evgenia
AU - MсElreavey, Kenneth
AU - Baronio, Federico
AU - Rey, Rodolfo
AU - Lopez Dacal, Jimena
AU - Darendeliler, Feyza
AU - Poyrazoglu, Sukran
AU - Kolesińska, Zofia
AU - Niedziela, Marek
AU - Claahsen-van der Grinten, Hedi L
AU - L T van den Akker, Erica
AU - Herrmann, Gloria
AU - Atapattu, Navoda
AU - Jain, Vandana
AU - Sharma, Rajni
AU - Bettendorf, Markus
AU - Konrad, Daniel
AU - Lenherr-Taube, Nina
AU - Holterhus, Paul Martin
AU - Fica, Simona
AU - Skae, Mars
AU - Russo, Gianni
AU - Stancampiano, Marianna Rita
AU - Gazdagh, Gabriella
AU - Davies, Justin H
AU - Mohamed, Zainaba
AU - Seneviratne, Sumudu Nimali
AU - Güran, Tülay
AU - Güven, Ayla
AU - Wasniewska, Malgorzata
AU - Mladenov, Vilhelm
AU - Verkauskas, Gilvydas
AU - Markosyan, Renata
AU - Korbonits, Marta
AU - Hiort, Olaf
AU - Frielitz-Wagner, Isabel Viola
AU - Ahmed, S Faisal
AU - Thankamony, Ajay
N1 - Publisher Copyright:
© 2025 The Author(s). Published by Oxford University Press on behalf of the Endocrine Society.
PY - 2025/12/1
Y1 - 2025/12/1
N2 - Background 46,XY gonadal dysgenesis is classified as complete (CGD) or partial (PGD) subtypes. The phenotype of PGD and the long-term outcome is not clearly defined. Objective To evaluate clinical features and pubertal outcome of PGD in a large cohort, using CGD as a comparator for diagnostic clarity. Methods Patients with 46,XY GD were identified from the I-DSD Registry and data on phenotype, genetics, biochemistry, gonadal histology, and pubertal development were collated in 3 categories; CGD (n = 100), PGD assigned female (PGDf, n = 107), and male (PGDm, n = 103) at birth. Results Most individuals with PGD presented with atypical genitalia in infancy, though, 18% of PGDf presented with delayed puberty and 8% with virilization. A genetic etiology was identified in 42% of the cohort, with common gene defects in SRY and WT1 in CGD and NR5A1 in PGD. Gonadal pre-/malignancy was found in 33.8% in CGD, 19.7% in PGDf, and 8.8% in PGDm. Among the PGDm (>13 years) with at least 1 gonad, 80% had spontaneous pubertal onset and 59% achieved Tanner G5 without hormone treatment. Labioscrotal gonads at presentation and testosterone response to human chorionic gonadotropin predicted onset of spontaneous puberty. In PGDf with gonads, 42% developed spontaneous virilization at puberty. Sex was reassigned in 16.1% and 5.3% of individuals with PGDf and PGDm, respectively. Conclusion This study highlights the heterogeneous phenotype of PGD and the consequent diagnostic challenge. Many PGD patients with preserved gonads have the potential to develop puberty spontaneously, though further study is needed to determine the risk of developing gonadal tumors.
AB - Background 46,XY gonadal dysgenesis is classified as complete (CGD) or partial (PGD) subtypes. The phenotype of PGD and the long-term outcome is not clearly defined. Objective To evaluate clinical features and pubertal outcome of PGD in a large cohort, using CGD as a comparator for diagnostic clarity. Methods Patients with 46,XY GD were identified from the I-DSD Registry and data on phenotype, genetics, biochemistry, gonadal histology, and pubertal development were collated in 3 categories; CGD (n = 100), PGD assigned female (PGDf, n = 107), and male (PGDm, n = 103) at birth. Results Most individuals with PGD presented with atypical genitalia in infancy, though, 18% of PGDf presented with delayed puberty and 8% with virilization. A genetic etiology was identified in 42% of the cohort, with common gene defects in SRY and WT1 in CGD and NR5A1 in PGD. Gonadal pre-/malignancy was found in 33.8% in CGD, 19.7% in PGDf, and 8.8% in PGDm. Among the PGDm (>13 years) with at least 1 gonad, 80% had spontaneous pubertal onset and 59% achieved Tanner G5 without hormone treatment. Labioscrotal gonads at presentation and testosterone response to human chorionic gonadotropin predicted onset of spontaneous puberty. In PGDf with gonads, 42% developed spontaneous virilization at puberty. Sex was reassigned in 16.1% and 5.3% of individuals with PGDf and PGDm, respectively. Conclusion This study highlights the heterogeneous phenotype of PGD and the consequent diagnostic challenge. Many PGD patients with preserved gonads have the potential to develop puberty spontaneously, though further study is needed to determine the risk of developing gonadal tumors.
KW - 46,XY gonadal dysgenesis
KW - differences/disorders of sex development
KW - gonadectomy
KW - sex reassignment
KW - spontaneous puberty
KW - virilization
UR - https://www.scopus.com/pages/publications/105021928297
U2 - 10.1210/clinem/dgaf223
DO - 10.1210/clinem/dgaf223
M3 - Article
C2 - 40208111
SN - 0021-972X
VL - 110
SP - e4086-e4100
JO - Journal of clinical endocrinology and metabolism
JF - Journal of clinical endocrinology and metabolism
IS - 12
ER -